Print Friendly Page

Protocol No. NRGGU002

Phase II/III

Age Group Adult

Scope National

Sponsor Type National

Title Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation following Radical Prostatectomy with or without Adjuvant Docetaxel

Applicable Disease Sites Prostate

Drugs Involved Firmagon (degarelix); bicalutamide; casodex (bicalutamide); degarelix; docetaxel; goserelin; lupron (leuprolide acetate); taxotere (docetaxel); zoladex (goserelin)

Status Open (affiliates only)

Participating Institutions Aspirus Wausau Hospital, Aspirus Regional Cancer Center; Langlade Memorial Hospital, Aspirus Regional Cancer Ctr